BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 35959560)

  • 1. Comparative effectiveness of group
    Spiller TR; Duek O; Buta E; Gross G; Smith NB; Harpaz-Rotem I
    Psychol Med; 2023 Jul; 53(10):4561-4568. PubMed ID: 35959560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yoga vs Cognitive Processing Therapy for Military Sexual Trauma-Related Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Zaccari B; Higgins M; Haywood TN; Patel M; Emerson D; Hubbard K; Loftis JM; Kelly UA
    JAMA Netw Open; 2023 Dec; 6(12):e2344862. PubMed ID: 38064219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Brief Exposure-Based Treatment vs Cognitive Processing Therapy for Posttraumatic Stress Disorder: A Randomized Noninferiority Clinical Trial.
    Sloan DM; Marx BP; Lee DJ; Resick PA
    JAMA Psychiatry; 2018 Mar; 75(3):233-239. PubMed ID: 29344631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the multiphase optimization strategy to adapt cognitive processing therapy (CPT MOST): study protocol for a randomized controlled factorial experiment.
    Sripada RK; Peterson CL; Dziak JJ; Nahum-Shani I; Roberge EM; Martinson AA; Porter K; Grau P; Curtis D; McElroy S; Bryant S; Gracy I; Pryor C; Walters HM; Austin K; Ehlinger C; Sayer N; Wiltsey-Stirman S; Chard K
    Trials; 2023 Oct; 24(1):676. PubMed ID: 37858262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Sloan DM; Marx BP; Acierno R; Messina M; Muzzy W; Gallagher MW; Litwack S; Sloan C
    JAMA Psychiatry; 2023 Nov; 80(11):1093-1100. PubMed ID: 37610727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterans' 12-month PTSD and depression outcomes following 2- and 3-week intensive cognitive processing therapy-based treatment.
    Held P; Smith LJ; Parmar AM; Pridgen SA; Smith DL; Klassen B
    Eur J Psychotraumatol; 2024; 15(1):2350908. PubMed ID: 38770596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in implementation of two evidence-based psychotherapies for PTSD in VA residential treatment programs: a national investigation.
    Cook JM; Dinnen S; Thompson R; Simiola V; Schnurr PP
    J Trauma Stress; 2014 Apr; 27(2):137-43. PubMed ID: 24668757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraumatic cognition change trajectories in veterans with PTSD who completed an intensive Cognitive Processing Therapy treatment program.
    Szoke D; Walker E; Christ N; Smith D; Held P
    Cogn Behav Ther; 2024 Jul; 53(4):423-435. PubMed ID: 38477982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine.
    Petrakis IL; Meshberg-Cohen S; Nich C; Kelly MM; Claudio T; Jane JS; Pisani E; Ralevski E
    Am J Addict; 2024 Apr; ():. PubMed ID: 38624259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of a Brief Family Intervention to Reduce Dropout Among Veterans in Individual Trauma-Focused Treatment: A Randomized Controlled Trial.
    Thompson-Hollands J; Lee DJ; Sloan DM
    J Trauma Stress; 2021 Aug; 34(4):829-839. PubMed ID: 33891718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment characteristics associated with symptom reduction during group cognitive processing therapy versus exposure therapy for PTSD: an exploratory study of Veterans.
    Hunt C; Casas B; Chiu PH; Smith LJ; Priorello L; Lee K; Estey M; Newsome MR; Williams MW
    Cogn Behav Ther; 2024 Jan; 53(1):70-86. PubMed ID: 37969001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive-behavioral group treatment for veterans diagnosed with PTSD: Design of a hybrid efficacy-effectiveness clinical trial.
    Sloan DM; Unger W; Gayle Beck J
    Contemp Clin Trials; 2016 Mar; 47():123-30. PubMed ID: 26718094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Session-level effects of cognitive processing therapy and prolonged exposure on individual symptoms of posttraumatic stress disorder among U.S. veterans.
    Moshier SJ; Mahoney CT; Bovin MJ; Marx BP; Schnurr PP
    J Consult Clin Psychol; 2024 Mar; ():. PubMed ID: 38546622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and reasons for veteran mental health service utilization following completion of evidence-based trauma-focused treatment for PTSD.
    Baier AL; Nugent S; Horton DM; Salameh H; Kehle-Forbes SM
    Psychol Serv; 2023 Nov; ():. PubMed ID: 37917477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Happens Next? Maintenance of Gains After Discharge From VA Residential PTSD Treatment.
    Grau PP; Harpaz-Rotem I; Ilgen MA; Ganoczy D; Sripada RK
    J Nerv Ment Dis; 2024 Apr; 212(4):197-204. PubMed ID: 38536046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans.
    Held P; Zalta AK; Smith DL; Bagley JM; Steigerwald VL; Boley RA; Miller M; Brennan MB; Van Horn R; Pollack MH
    Eur J Psychotraumatol; 2020 Aug; 11(1):1789324. PubMed ID: 33029327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veterans with poor PTSD treatment adherence: Exploring their loved ones' experience of PTSD and understanding of PTSD treatment.
    Thompson-Hollands J; Burmeister LB; Rosen CS; O'Dougherty M; Erickson EPG; Meis LA
    Psychol Serv; 2021 May; 18(2):216-226. PubMed ID: 31436444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an implementation model: a national investigation of VA residential programs.
    Cook JM; Dinnen S; Coyne JC; Thompson R; Simiola V; Ruzek J; Schnurr PP
    Adm Policy Ment Health; 2015 Mar; 42(2):147-56. PubMed ID: 24817625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain derived neurotrophic factor and treatment outcomes among veterans attending an intensive treatment program for posttraumatic stress disorder.
    Zalta AK; Voigt RM; Stevens SK; Held P; Raeisi S; Boley RA; Keshavarzian A; Pollack MH
    J Psychiatr Res; 2024 May; 173():1-5. PubMed ID: 38437783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cognitive-behavioral therapy for PTSD improve perceived health and sleep impairment?
    Galovski TE; Monson C; Bruce SE; Resick PA
    J Trauma Stress; 2009 Jun; 22(3):197-204. PubMed ID: 19466746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.